FTC Staffing Up For More Biopharma Merger Oversight
Executive Summary
The Federal Trade Commission plans to bolster its oversight of biopharma mergers by adding staff to "specialize" in the "increasingly complex" actions in this sector, according to the agency's budget request for fiscal year 2011